The promise of rapid weight loss has led millions to embrace popular GLP-1 medications, but behind the marketing campaigns and celebrity endorsements lies a troubling reality. Many patients who trusted these drugs now face serious, life-altering complications that manufacturers allegedly knew about but failed to disclose. Severe gastroparesis, blood clots, and gastrointestinal injuries are only some of these dangers.
Estey & Bomberger, LLP is fighting for those harmed by dangerous weight loss medications nationwide. Our product liability attorneys specialize in handling dangerous drug cases and have the resources to take on powerful pharmaceutical companies that put profits before patient safety. If you were harmed by Ozempic, Mounjaro, or another drug, we urge you to schedule a free consultation and explore your legal options.
Why Trust the Dangerous Products Lawyers at Estey & Bomberger, LLP?
- We dedicate our entire practice to fighting large corporations on behalf of injured consumers. When you work with our firm, you receive aggressive representation and compassionate guidance to help you seek justice.
- With a 99% case success rate and hundreds of millions of dollars recovered for our clients, Estey & Bomberger, LLP knows what it takes to prove weight loss drug lawsuits. We will leverage our knowledge and resources to build a strong claim for you.
- Your attorney will work on a contingency fee basis, meaning you pay no legal fees unless we win your case. This allows you to pursue justice against pharmaceutical companies without financial risk.
Dangerous Side Effects Caused by Weight Loss Drugs
GLP-1 receptor agonists work by mimicking your body’s natural GLP-1 hormone, which controls blood sugar and appetite. These medications slow stomach emptying, increase feelings of fullness, and trigger insulin production. While manufacturers marketed these effects as beneficial for weight loss, they failed to adequately warn patients about the serious risks involved.
Patients have suffered from devastating side effects, including:
- Gastroparesis, also known as stomach paralysis
- Blood clots, leading to deep vein thrombosis and pulmonary embolisms
- Vision loss, including sudden blindness and optic nerve damage
- Intestinal blockages and bowel obstructions
- Gallbladder complications
- Persistent vomiting
- Esophageal injuries from repeated vomiting
- Severe malnutrition from the inability to keep food down
If you have developed any of these conditions after taking GLP-1 weight loss medications, you may qualify for legal action against the manufacturer involved. By filing a claim, you can recover damages for medical expenses, lost income, pain and suffering, and other losses related to your condition.
Which Weight Loss Drugs Are Involved in Lawsuits?
Ozempic
Novo Nordisk’s Ozempic received FDA approval in 2017 for treating type 2 diabetes, but the company quickly recognized its weight loss potential. Despite lacking FDA approval for weight loss, Novo Nordisk began marketing Ozempic’s weight reduction benefits. However, the company failed to disclose the risk of gastroparesis, a condition where the stomach becomes paralyzed and cannot properly empty food into the small intestine.
Patients who develop gastroparesis after taking Ozempic face permanent changes to their ability to eat and digest food, often requiring feeding tubes or frequent hospitalizations for malnutrition. If you developed gastroparesis after taking Ozempic, you may have grounds for a lawsuit against Novo Nordisk.
Novo Nordisk allegedly knew about the gastroparesis risk but failed to adequately warn patients and doctors. The company’s label mentions only a “minor delay in gastric emptying” without explaining that this could lead to chronic stomach paralysis. Many patients had no idea they risked developing a permanent, life-altering digestive condition.
Plaintiffs in Ozempic lawsuits argue that Novo Nordisk failed to conduct sufficient clinical trials to identify gastroparesis risks, concealed safety information from regulatory agencies and consumers, and provided inadequate warnings about this serious side effect.
Wegovy
Wegovy contains the same active ingredient as Ozempic but at higher doses specifically approved for weight loss and obesity treatment. Despite FDA approval for weight management, patients have developed the same serious complications, including gastroparesis and other gastrointestinal injuries.
These lawsuits focus on Novo Nordisk’s alleged failure to adequately warn users about gastroparesis and other severe digestive complications. Patients have suffered intestinal blockages, obstructions, and permanent stomach paralysis that dramatically impacts their quality of life. Many require ongoing medical treatment and dietary restrictions as a result of their conditions.
Mounjaro
Eli Lilly’s Mounjaro has caused gastroparesis and other serious gastrointestinal complications in patients seeking weight loss benefits. The company’s initial safety materials failed to mention gastroparesis as a potential risk, leaving patients unaware of this devastating possibility.
Mounjaro lawsuits claim Eli Lilly failed to warn consumers about gastroparesis and other severe complications that have permanently affected patients’ lives. Patients who developed gastroparesis after taking Mounjaro face the same life-altering consequences as those harmed by other GLP-1 medications: permanent digestive dysfunction, chronic pain, malnutrition, and frequent medical care.
Rybelsus
Rybelsus is Novo Nordisk’s pill version of semaglutide, carrying similar gastroparesis risks to its injectable counterparts. Patients may have believed that Rybelsus was safer than injections, but lawsuits reveal similar complications.
Patients have developed gastroparesis, vision changes, blood clots, and gastrointestinal injuries. Like Ozempic and Wegovy claims, Rybelsus lawsuits allege Novo Nordisk failed to adequately warn about these serious risks.
Trulicity
Eli Lilly’s Trulicity has caused gastroparesis along with other serious complications including liver and kidney disease and pancreatitis. Patients who trusted Trulicity for diabetes management or weight loss now face permanent digestive complications that require ongoing medical care and significantly impact their daily lives. Now, they are filing lawsuits against Eli Lilly for failing to provide adequate warnings about these side effects.
Advantages of Legal Representation in Weight Loss Drug Lawsuits
Pharmaceutical companies employ teams of attorneys and expert witnesses to defend against injury claims. You need equally skilled legal representation to level the playing field. The weight loss drug attorneys at Estey & Bomberger, LLP know how to establish the link between GLP-1 medications and your gastroparesis or other serious injuries and prove your right to recovery.
We thoroughly analyze complex medical records, clinical trial data, and FDA safety communications to build a compelling case on your behalf. Our firm actively participates in the mass tort proceedings currently surrounding these medications, leveraging collective evidence to prove your right to recovery. We handle every part of your case so that you can focus on your health.
Contact Estey & Bomberger, LLP for a Free Consultation Today
You deserve compensation for the harm caused by dangerous weight loss medications. Estey & Bomberger, LLP will fight tirelessly to hold pharmaceutical companies accountable. Contact us at (800) 260-7197 for your free consultation and learn how we can help you seek the justice you deserve.